Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations
Open Access
- 23 August 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 34 (1) , 145-156
Abstract
Melorheostosis is a rare hyperostotic disease of the long bones classically characterized by a “dripping candle‐wax” radiographic appearance. We recently described somatic activating mutations in MAP2K1 as a cause of melorheostosis. Here, we report distinguishing characteristics of patients with MAP2K1‐positive melorheostosis. Fifteen unrelated patients with radiographic appearance of melorheostosis underwent paired biopsies of affected and unaffected bone for whole‐exome sequencing, histology, and cell culture. Eight patients with mutations in MAP2K1 in affected bone were compared to the seven MAP2K1‐negative patients to identify distinguishing characteristics. Patients with MAP2K1‐positive melorheostosis had a distinct phenotype with classic “dripping candle‐wax” appearance on radiographs (p = 0.01), characteristic vascular lesions on skin overlying affected bone (p = 0.01), and higher prevalence of extraosseous mineralization and joint involvement (p = 0.04 for both). Melorheostotic bone from both MAP2K1‐positive and MAP2K1‐negative patients showed two zones of distinct morphology—an outer segment of parallel layers of primary lamellar bone and a deeper zone of intensely remodeled highly porous osteonal‐like bone. Affected bone from MAP2K1‐positive patients showed excessive osteoid (p = 0.0012), increased number of osteoblasts (p = 0.012) and osteoclasts (p = 0.04), and increased vascularity on histology in comparison to paired unaffected bone which was not seen in affected bone in most MAP2K1‐negative patients. The identification of a distinct phenotype of patients with MAP2K1‐positive melorheostosis demonstrates clinical and genetic heterogeneity among patients with the disease. Further studies are needed to better understand the underlying pathophysiology and associated skin findings. © 2018 American Society for Bone and Mineral Research.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
This publication has 19 references indexed in Scilit:
- High prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemiasNature Genetics, 2013
- The RASopathiesAnnual Review of Genomics and Human Genetics, 2013
- McCune-Albright syndromeOrphanet Journal of Rare Diseases, 2008
- Deactivating Germline Mutations in LEMD3 Cause Osteopoikilosis and Buschke-Ollendorff Syndrome, but Not Sporadic MelorheostosisJournal of Bone and Mineral Research, 2007
- Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosisNature Genetics, 2004
- Cutaneous Manifestations of Proteus SyndromeArchives of Dermatology, 2004
- Osteosarcoma arising in a femur with melorheostosis and osteopathia striataSkeletal Radiology, 2002
- Melorheostosis: a review of 23 casesEuropean Radiology, 2001
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- Activating Mutation of GSα in McCune-Albright Syndrome Causes Skin Pigmentation by Tyrosinase Gene Activation on Affected MelanocytesHormone Research in Paediatrics, 1999